Invasive Aspergillosis
📧 Sign up to get email alerts when something new happens for Invasive Aspergillosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-06-01FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig. The page provides no details on the specific change.
-
FDA approval · 2010-11-21FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig. The supplement updates the labeling for the antifungal…
-
CLINICAL_TRIALS research · 2010-08-05Clinical Trial Update: Correlation Between Circulating Galactomannan and Beta-D-glucan and Clinical Outcome of Invasive Aspergillosis
A clinical trial update examining whether circulating galactomannan and beta-D-glucan levels correlate with clinical outcomes in invasive As…
-
CLINICAL_TRIALS research · 2010-06-28Clinical Trial Update: Surveillance for Nosocomial Infections in Pediatric Cancer Patients
The update describes a clinical trial investigating surveillance for nosocomial infections, bloodstream infection, and invasive aspergillosi…
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene) [Phase 4]
A Phase 4 trial evaluating the combination of voriconazole and anidulafungin for invasive aspergillosis in patients unable to take polyene w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients
A completed clinical trial assessing voriconazole as prophylaxis to prevent aspergillosis in lung transplant recipients.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Update on a clinical trial evaluating invasive aspergillosis after allogeneic hematopoietic stem cell transplantation; current status of the…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). [Phase 2, Phase 3]
A safety and effectiveness study evaluating intravenous anidulafungin in combination with AmBisome for invasive aspergillosis (Phase 2/Phase…
-
FDA approval · 2008-03-10FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) filed by Roerig.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis [Phase 3]
This update relates to a Phase 3 randomized trial comparing voriconazole with amphotericin B for invasive aspergillosis that has completed e…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis [Phase 2, Phase 3]
Phase 2/3 trial evaluating inhaled liposomal amphotericin B to prevent invasive aspergillosis has completed.
-
FDA label_change · 2006-05-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig, updating the product labeling.